Mussel contains a variety of adhesion proteins, among which, Mytilus galloprovincialis foot protein type 5 (Mgfp-5) is one of the major proteins required for substrate adhesion. The labor-intensive nature and insufficiency of the extraction process have frequently resulted in very little purified recombinant Mgfp-5. These prompt technologies such as chemical synthesis and genetic engineering are employed to overcome these limitations. In this study, successful expression and purification of the recombinant Mgfp-5 using Escherichia coli BL21 (DE3) and affinity chromatography were reported. Production yield of 12.25% and purity of 96.92%, respectively were observed. The 3,4-dihydroxyphenylalanine (DOPA) content (9.60 pmol/g) and the adhesion (1 116 nN) in modified recombinant Mgfp-5 were 9.32 times and 1.6 times as great as those in the unmodified recombinant Mgfp-5, respectively. Recombinant Mgfp-5 at a concentration of 9.6 mg/L had little cytotoxicity on mouse L-929 fibroblast cells, which was toxic at first in cytotoxicity test, and a concentration of not more than 20 μg/mL would not lead to hemolysis of rabbit erythrocytes. In this case, recombinant Mgfp-5 is biosecure, providing the foundation for Mgfp-5 manufacturing as well as the development of clinical biological adhesive.
INTRODUCTION
Marine mussel secretes a specific adhesive protein by its byssus to survive an aqueous environment. This was first observed in the 1980s by researchers and is called Mytilus adhesive protein (MAPs) or Mytilus foot protein (Mfps) (Waite and Tanzer, 1981) . MAPs are one of the potential resources in the field of biotechnological applications for its strong adhesion, flexibility, water resistance and biodegradability, among others (Dove and Mussel byssus can be divided into proximal thread and distal plate, which secretes 6 types of proteins (Mfp-1 to and three kinds of precollagens (preCol), namely, preCol-D, preCol-P and preCol-NG MAPs (Rego et al., 2016) . These MAPs are rich in unusual amino acid 3,4-dihydroxyphenylalanine (DOPA) that can be catalyzed by polyphenol oxidase, which is central to the cross-linking reactions of cohesive curing and adhesive surface bonding (Silverman and Roberto, 2007) . It has been proved that DOPA content is correlated with the adhesive strength of MAPs (Yu et al., 1999) . Mfp-5 is located in the byssus plate where the DOPA content is approximately 30% (Waite, 2011) . Hence, it directly plays a major role in adhesion (Waite, 2011) .
Becton, Dickinson (BD Bioscience) companies have extracted the Mfp-1 and Mfp-2 mixtures (Cell- Tak   TM   ) which have been applied in biological adhesive products using the natural method. However, only one (1) mg of the protein can be obtained from about 10 000 mussels by natural extraction. Inefficiency and high cost of such natural extraction process has greatly restricted the application of MAPs. On this basis, chemical synthesis and genetic engineering have been widely applied, attempting to solve the above-mentioned difficulties (Gim et al., 2008; Platko et al., 2008) . In this study, the recombinant Mytilus galloprovincialis foot protein type 5(Mgfp-5) was successfully expressed in Escherichia coli BL21 (DE3) and purified, and the cytotoxicity of protein should be further tested in order to examine whether the recombinant Mgfp-5 could reach the safety standard or not.
The current study focused on the issue of, how recombinant Mgfp-5 could be expressed in E. coli and purified by nickel (Ni 2+ ) column affinity chromatography. Subsequently, biological adhesion of recombinant Mgfp-5 was measured by glass coating and atomic force microscopy (AFM). Meanwhile, biological safety was analyzed by cell cytotoxicity test (Cell Counting Kit and CCK 8 qiagen method) and hemolysis test, in order to lay a good foundation for the development and application of sources of biological adhesive.
MATERIALS AND METHODS

Expression of recombinant Mgfp-5 protein
The pUC57 containing the Mgfp-5 gene (constructed and preserved in our laboratory) was constructed according to the sequence of cDNA Mgfp-5 (Gen Bank: AY521220. 1) gene. The plasmid pET28a-mgfp was constructed for Mgfp-5 gene and pET-28a vector using the following primers: F (Nde I cleavage site and protecting bases): 5'-GGAATTCCATATGAGTTCTGAAGAAT, and R (EcoR I cleavage site protecting bases): 5'-CGGAATTCCTAACTGCTACCACCT. PCR amplification program: 94°C pre-denaturation 5 min; 94°C denaturation 30 s; 55°C annealing 30 s; 72°C extension 45 s, cycle 34 times, 72°C extension 10 min were used. The purified amplified product and pET-28a vector were digested with Nde I and EcoR I, respectively, which were ligated with T4-DNA ligase and then transformed into E. Lv et al. 1841 coli BL21 on LB plates containing 50 mg/L Kan at 37°C overnight culture. Monoclonal E. coli BL21 lacking the Mgfp-5 gene and E. coli BL21-Mgfp with the Mgfp-5 gene were cultured overnight in Luria Broth (LB, contained 50 Kan) followed by centrifugation at 200 r/min and 37°C, respectively. Plasmid pET28a-mgfp was extracted from E. coli strains, and PCR DNA products were separated on 0.8% (w/v) agarose gel.
Bacteria were propagated and cultured at a proportion of 1:100. Subsequently, bacterial cultures were induced by isopropyl β-Dthiogalactoside (IPTG, 1.0 mmol/L) at OD600 = 0.8. 4 h later, 1.0 mL bacteria liquid was centrifuged at 4°C and 12 000 r/min for 10 min, and cells were collected. Expression of recombinant Mgfp-5 was analyzed by 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Purification of recombinant Mgfp-5 protein
E. coli BL21-Mgfp were cultured using batch bioreactor (Sartorius). Subsequently, recombinant Mgfp-5 was purified using Ni 2+ affinity purification under natural or denaturing conditions, containing 8 mol/L urea as previously described (Lv et al., 2016) . Following this, western blotting using His6 tag was carried out.
The content of the protein was measured using a BCA Protein Assay Kit-Reducing Agent Compatible (Thermo Fisher Scientific, China) according to the manufacturer's instructions, with bovine serum albumin as the standard. The purity from the purified protein was evaluated by gradation analysis, while the pure protein was freeze-dried and stored at -80°C.
Modification of proteins
Purified protein was dissolved in phosphate buffered saline (PBS) (NaCl 0.1 mmol/L, KCl 3 mmol/L, Na2HPO4·12H2O 10 mmol/L, KH2PO4 2 mmol/L) containing 10 mmol/L ascorbic acid and 20 mmol/L sodium borate (0.1 mol, pH 7). In order to modify tyrosine residues to DOPA, the solution was irregularly oscillated for 2 h at room temperature after adding 10 U/mL tyrosinase. Recombinant Mgfp-5 was collected by ultrafiltration and dialysis in 5% acetic acid. Bovine serum albumin (BSA) was used as the negative control and Cell-Tak TM as the positive control.
DOPA content analysis
DOPA content was measured by nitroblue tetrazolium and potassium glycinate (NBT/glycinate, 0.24 mmol/L NBT in 2 mo/L potassium glycinate, pH 10) staining assay. The DOPA standard (1 μg/mL) was dispensed (0, 2, 4, 8, 16 and 20 μL) and added into six labeled wells in a 96-cell well format. The final volume of each well was adjusted to 20 μL with Milli-Q water and NBT/Glycinate (180 μL) was added. All reagents were pipetted into tubes immersed in an ice-water bath. This reaction started by incubating in water bath at 25°C in the dark. An hour later, optical density (OD) was measured at a wave length of 530 nm. DOPA quantity of samples was determined from the standard curve and Milli-Q water was used as a negative control.
Adhesion analysis
Protein samples (10 μL of 1.00 mg/mL) were added into the glass surface and incubated under a humid environment at 25°C for 12 h. The surfaces were dried using natural drying and each was washed thoroughly with Milli-Q water for 2 h with shaking. Protein coating spots were visualized using Coomassie brilliant blue staining. Images of protein spots were captured using a scanner and were analyzed by PDQUest software according to the protocols provided by Bio-Rad. BSA was used as a negative control.
AFM cantilevers were modified in accordance with techniques adopted by Ducker et al. (1991) . The spring constant of AFM (SPM-9500J3) was 5 N/m. A lass sphere (Duke Scientific) of 5 μm in diameter was attached to the tip of cantilever using an epoxy resin (Vantico) under microscope, and the modified cantilever was cured at room temperature for 24 h. The modified AFM cantilevers were mounted onto cells and allowed to contact with 2 μL sample solutions (1.0 mg/mL) on glass slides for 20 min; this allow proteins to adsorbed on the glass bead.
After 10 min of contact, a force-distance curve was obtained by separating the modified cantilever from the glass surface. The pulling velocity for the force-distance curve was measured as 1 mm/s. Recombinant Mgfp-5 was dissolved in PBS and the final concentration was 1 mg/mL, which adhered to spearhead (polytetrafluoroethylene) and centrifugal tube cover (propathene) with different sizes or weights. Macroscopic adhesion conditions of protein were observed.
Cytotoxicity test
According to the rule of MAP wound dressing in the use of the human body (usage amount of the 2% human body area less than 1 mL per day), the amount of MAP was 3.0 μg/cm 2 (Liu et al., 2013) . In this study, the mass concentration of Mgfp-5 should be 9.6 mg/L on the base of 96 well culture plate (Per well area is 0.32 cm 2 and medium is 0.1 mL in per well). L-929 cells cultured in the Dulbecco's modification of Eagle's medium Dulbecco (DMEM) supplemented with 10% fetal bovine serum (100 μL) were added to the 96-well cell plate and cultured to cell adherence in a CO2 incubator at 37°C.
After replacing fresh broth, protein samples (100 μL of 9.6 mg/L) were added in every well. Cell morphology was evaluated 2 days later using inverted phase contrast microscope. Subsequently, CCK-8 (Rainbio) (10 μL) was added into each well and the absorbance value (A) was recorded at 450 nm after 4 h. Relative growth rate (RGR) was calculated using:
Cytotoxicity of recombinant Mgfp-5 was evaluated according to ANSI/AAMI/ISO 10993-5:1999 (Table 1 ). In addition to the blank (cell culture medium DMEM), a negative (PBS) and positive control (9.6 mg/L dimethyl sulfoxide, DMSO) was included in the experiment. All assays were repeated for at least three times to ensure the reproducibility.
Hemolytic test
On entering of Mgfp-5 into the body, hemolysis is one of the most important concerns regarding its safety. In the present study, 2% of the rabbit red blood cell (RBC) suspension was obtained by centrifugation and suction to remove the serum from the blood and further washed five times with sterile normal saline solution. Cells were diluted to 2/100 in a volume with normal saline solution.
2 mL of the diluted RBC suspension was mixed with 2 mL recombinant Mgfp-5 solution at different concentrations, ranging from 5, 10, 20 to 25 μg/mL and incubated immediately at 37°C. Incubation of all was sequentially performed for 0.5, 1, 2 and 3 h, followed by centrifugation at 1 000 rpm for 15 min. The hemolysis of RBC was observed and the hemolysis ratio was evaluated. In A All assays were repeated at least three times to ensure the reproducibility.
RESULTS
Expression of recombinant Mgfp-5 protein
The PCR assay results are indicated in Figure 1A ; these showed amplification of the specific 260-bp band of Mgfp-5 gene fused with hexahistidine affinity ligand, which is clearly absent with the negative control. Recombinant Mgfp-5 was successfully expressed with the apparent molecular weight on SDS-PAGE gel, being greater (about 15 KD) than the predicted one (about 11.4 KD) ( Figure  1B ) which might be attributed to the higher isoelectric point (9.8) of recombinant Mgfp-5 as well as the combination with SDS (Hwang et al., 2010) .
Purification and modification of proteins
Recombinant Mgfp-5 under natural or denaturing conditions (containing 8 mol/L urea) was analyzed. SDS-PAGE analysis indicated that recombinant Mgfp-5 was successfully expressed using IPTG induction and was purified by Ni 2+ column chromatography ( Figure 1C ). In addition, yield of dissociated recombinant Mgfp-5 under denaturing condition was much higher than that under natural conditions. Recombinant Mgfp-5 (37.00±2.55 mg) was purified from 1 L denaturing lysis buffer containing 302.00±16.55 mg of total protein, with the efficiency of about 12.25% and the purity reaching 96.92%. The analysis also showed that some recombinant Mgfp-5 exist as a dimer. Western blot analyses confirmed that the purified protein was indeed a recombinant Mgfp-5 ( Figure 1D ).
DOPA content and function analysis
In order to assess the association between DOPA content and protein adhesion, DOPA content was measured. We performed a comparative study with BSA as a negative control and Cell-Tak TM as a positive control. Cell-Tak TM is a commercially available naturally extracted Mytilus edulis adhesive-protein mixture of fp-1 and fp-2 that contains DOPA residues in 5% acetic acid buffer. Recombinant Mgfp-5 and Cell-Tak TM was modified, and DOPA content of the modified recombinant Mgfp-5 (9.6 pmol/g) was discovered to be 9.32, 2.35 and 1.58 times higher than that of the unmodified recombinant Mgfp-5 (1.03 pmol/g), unmodified Cell-Tak TM (4.09 pmol/g), and modified Cell-Tak TM (6.07 pmol/g), respectively ( Figure  2A ). These findings suggested that part of tyrosine residues in recombinant Mgfp-5 had been oxidized to DOPA.
A simple coating assay was performed to test the adhesive ability of recombinant Mgfp-5. As shown in Figure 2B , recombinant Mgfp-5 and Cell-Tak TM could still adhere to the glass surface, while BSA was almost cleared and cleaned after each surface was washed thoroughly with Milli-Q water. The lighter spot color produced indicated that the adhesive intensity of modified recombinant Mgfp-5 was twice as strong as that of unmodified recombinant Mgfp-5, quantified by PDQest software ( Figure 2C ). This result demonstrated that modified recombinant Mgfp-5 contributed to the improvement of adhesive ability of the recombinant Mgfp-5.
AFM was selected to further investigate the adhesive ability of the recombinant Mgfp-5. As was shown in Figure 2D , adhesive force of modified recombinant Mgfp-5 (~1116.67 nN) was much higher than that of unmodified recombinant Mgfp-5 (~19.67 nN) and Cell-Tak TM (698.33 nN). However, it was interesting that adhesive force of modified Cell-Tak TM showed a descending trend, which might be related to the fact that commercial Cell-Tak TM had already contained enough DOPA, while the intermolecular cross-link of DOPA through oxidizing would affect its adhesive ability, leading to reduced adhesive force.
Adhesion used for laboratory plastic consumables, including spearhead and centrifugal tube cover of different sizes or weights was tested ( Figure 2E ). It was discovered that modified Mgfp-5 and unmodified CellTakTM could easily and completely adhere to these items within 10 min. It took 30 min for the modified Cell-TakTM to complete cross-linking for adhesion. More seriously, adhesion of unmodified recombinant Mgfp-5 took about 12 h or even longer to fall off.
Cytotoxicity test
L-929 cells were incubated in a CO 2 incubator at 37°C and monitored after 2 days. As shown in Figure 3 , L-929 cells of blank control group (a) attached well on the bottom of the plate. The online cells were clear with diamond or flattened spindle shape. Cells in negative control (b) and test groups (d) kept normal growth condition with no cytolysis observed, but cell density was slightly lower than that of the blank control group.
The cellular structure in a positive control group (c) was damaged. A large number of black spots were observed in the field of view, indicative of cell death occurring in nearly all cells. CCK-8 assay was used to measure the RGR and cytotoxicity (Table 2) . RGR of positive control DMSO was 12.11±0.10% and the cytotoxicity of DMSO was in grade 4. RGR of test group with recombinant Mgfp-5 (RGR Mgfp = 90.36±0.19%) was close to that of positive control (RGR PBS = 93.12±0.07%). The cytotoxicity of recombinant Mgfp-5 was in grade 1 according to Table  1 , which means that recombinant Mgfp-5 (9.6 mg/L) has a very good cytocompatibility. Figure 4 displayed the experimental image of hemolysis test with different concentrations and incubation times which was accompanied by a clear sediment and colorless transparent supernatant in groups 1, 2, 3 and negative controls (Sterile 0.9% sodium chloride solution) with hemolysis-free, while positive controls and groups 4 showed a little sediment and bright red supernatant with apparent hemolysis (Table 3) . Table 4 shows that the maximum concentration of Mgfp-5 at 20 μg/mL did not lead to a severe hemolysis within 3 h incubation by hemolysis ratio. Hemolysis ratio of recombinant Mgfp-5 with 20 μg/mL for 3 h was 2.74% (Table 4 ). According to ANSI/AAMI/ISO 10993-4:2002/A1:2006, the upper limited value of hemolysis index was 5%. Thus, the recombinant Mgfp-5 with 20 μg/mL has no hemolysis.
Hemolysis test
DISCUSSION
An impediment to further understand the unique adhesion and mechanism of MAPs is the lack of sufficient and pure protein. Large quantities of MAPs are needed to perform research and development for commercial adhesives. Existing approaches for natural extraction of Mgfp-5 are associated with several disadvantages, including low yield, being easily solidified and difficult to purify (Strausberg and Link, 1990) , which might have prompted researchers to turn to genetic engineering for protein Mgfp-5 extraction.
Prokaryotic genetic engineering was one of the preferred techniques for example recombinant Mgfp-5 from M. galloprovincialis as reported by Hwang et al. (), which was expressed in E. coli and only micro test of related function was conducted subsequently, rather than its biosafety (Hwang et al., 2004) . Recombinant Mgfp-5 was also expressed in E. coli after optimizing the conditions for both expression and purification as shown in previous research. This result showed 16% yield and a better purity of 96% (Lv et al., 2016) . Under such conditions, the bioreactor was used to produce recombinant Mgfp-5 in quantities (302.00±16.55). The yield of the recombinant Mgfp-5 was increased from 8.3 to 12.25% when 8 mol /L urea was added into the lysis buffer.
Mussel foot has a good adhesion in the water environment. The reason is that the DOPA in the protein has an extremely important role, which is the binding of DOPA to the substrates and the internal cross-linking of the proteins. All these proteins contain DOPA, formed by post-translational modification of tyrosine and have high isoelectric points (IEP) which differ vastly in sequences. Since DOPA can be oxidized and transformed to quinones and thus catalyze 1,2-benzenediols redox cycling at an alkaline pH, in the presence of potassium glycinate as a reductant, the released superoxide reduces NBT to formazan, therefore, allows a specific staining of DOPA-rich proteins (Paz et al., 1988) . Then, modified approach of NBT/glycinate staining for the quantitative analysis of DOPA in recombinant Mgfp-5 is used.
Among the MAPs, the protein Mfp-5 had a small molecular-weight which contained a lot of DOPA (about 30%) (Hwang et al., 2004) . Recombinant Mgfp-5 in E. coli also contained the majority of tyrosine residues, which could be modified to DOPA using tyrosinase (Hwang et al., 2010) . However, excessive oxidation of DOPA is 
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"+", completely hemolysis; "-", hemolysis-free "±"; part of the hemolysis, 1-4, represent recombinant Mgfp-5 solution of 5, 10, 20 and 25 μg/mL, respectively. resulted in self-ligation, rendering reduced protein adhesion. Researchers selected sodium borate and ascorbic acid to maintain the stability and protein adhesion of DOPA (Kan et al., 2014; Tatehata et al., 2000) . In this study, sodium borate and ascorbic acid were added to protect DOPA from self-ligation during modification process. It was found in this study that DOPA content of modified recombinant Mgfp-5 (9.6 pmol/g) was about 9.32 times higher than that of unmodified recombinant Mgfp-5 which led to significantly improved adhesion. At the same time, it could also be observed that adhesion of commercial Cell-Tak TM decreased is accompanied by the increase in DOPA content possibly because it typically comes with enough DOPA. DOPA content would be increased while adhesion would be decreased once DOPA was further modified.
Atomic force microscopy was applied in detecting the Surface texture of various materials by atomic-level imaging, through which the surface friction, adhesion force and hardness could be determined. Based on this analysis, the adhesion force of modified recombinant Mgfp-5 was better than that observed in commercialized Cell-Tak TM , which might be due to the combination of Mfp-1 with Mfp-2, as well as the lower content of DOPA than that of Mfp-5 chosen in the commercial Cell-Tak TM . Therefore, both the content of DOPA and the adhesion force of commercialized Cell-Tak TM were inferior to those of recombinant Mgfp-5 that had been modified by tyrosinase. Implant materials must have good biocompatibility because they will directly contact with tissues and cells after implanted into body. As a new biomaterial for adhension, it is important to evaluate its biosafety from experimental study to clinical application. The common method is to implant the test material into the body of an animal. However, implantation in vivo is limited by the long experimental period, complicated operation process, complex body environment and parameter control, among others (Wang et al., 2012; Lee et al., 2016) . In contrast, experiments conducted in vitro are relatively simple and their reproducibility can easily be controlled (Li et al., 2015) .
In ANSI/AAMI/ISO 10993-5:1999 standards, the cytotoxicity test is generally accepted as the first chosen item on account of convenience, fastness, high sensitivity and saving animal, etc. L929 cells are the first and most widely used cell line in cytotoxic test. L929 cells have the merit of stable passage, fast multiply, low condition for culture in vitro, being used for many materials cytotoxic test. The CKK-8 assay is sensitive to detect toxicity of materials and consistent with the toxicity experiment results in animals, which is considered to be a good method in evaluating the cytotoxicity of medical material in vitro (Li et al., 2016) . According to the rule of MAP wound dressing in the use of the human body (Usage amount of the 2% human body area less than 1 mL per day), the amount of MAP was 3.0 μg/cm 2 (Liu et al., 2013) . Therefore, the mass concentration of Mgfp-5 should be 9.6 mg/L on the base of 96 well culture plates.
In the current study, the RGR of recombinant Mgfp-5 at a concentration of 9.6 mg/L is above 90% and cytoxicity is grade 1 at 2 days. Therefore, the recombinant Mgfp-5 is consistent with medical standard of biomaterial. The L-929 cells morphology cultured in recombinant Mgfp-5 had no significant difference as compared to the control and is well attached at the bottom of the culture plate, which demonstrated that recombinant Mgfp-5 had no apparent cytotoxicity and could promote cell proliferation without affecting their normal function.
The hemolysis test is based on the degree of erythrolysis and hemoglobin dissociation while the material contacts RBC in vitro. ISO indicate that medical biomaterials which will be applied to the body and to biological tissue ought to be evaluated by the hemolysis test (ANSI/AAMI/ISO 10993-4:2002/A1:2006) . Hemolysis is a phenomenon of hemoglobin release which results in erythrolysis. Besides the endogenic hemolytic factors such as abnormity of red blood membranes and hemoglobin, there are some kinds of extrinsic factors such as physic agent on material surface, which can lead to cytotoxicity or may result in machinery damage to RBC. Generally, if hemolysis activity is observed in the hemolysis test, the material shows toxic.
In this study, the fresh rabbit blood was added into the test negative and positive control groups. The results show that the hemolytic ratio of recombinant Mgfp-5 when the concentration was 20 μg/mL is 2.7%, which is lower than the national and international standards of 5%. According to ANSI/AAMI/ISO 10993-4:2002/A1:2006, it suggests that protein with less than 20 μg/mL do not harm the RBC.
